NovoCure (NVCR) Priced

Markets a wearable electric field device for treating glioblastoma brain cancer.

Health Care - Health Care Equipment & Supplies

IPO Performance
Latest Trade $7.53 -0.18 (-2.3%)
First Day Return -16.9%
Return from IPO -65.0%
 
NovoCure IPO News more
  • .
IPO Data
IPO File Date 08/31/2015
Offer Price $22.00
Price Range $23.00 - $24.00
Offer Shares (mm) 7.5
Deal Size ($mm) 165
 
IPO Data
IPO Date 10/01/2015
Offer Price $22.00
Price Range $23.00 - $24.00
Offer Shares (mm) 7.5
Deal Size ($mm) $165
 
Underwriters
more
Business Overview
Markets a wearable electric field device for treating glioblastoma brain cancer.
Markets a wearable electric field device for treating glioblastoma brain cancer.
more
Company Data
Headquarters St Helier, , Jersey
Founded 2000
Employees 258
Website www.novocure.com
 

Performance vs. IPO Index (IPOUSA)